Following a lackluster 2024, shares of major drug markers kicked off 2025 with an upbeat quarterly results reading.

The big pharma sector is one that’s generally fallen out of favor for many investors over the past few decades, as large ...

The Arkansas General Assembly gaveled in a new legislative session last month in Little Rock and members of both the House ...

US aid freeze affects HIV and malaria supply chains, FDA postpones rare disease events, and a leap in Texas measles cases. Meanwhile, Mirum Pharma's drug gets FDA approval, Eli Lilly invests in a ...

While the "Make America Healthy Again" movement has gone all-in on Trump, progress on healthy food and toxic chemicals will ...

The Make America Healthy Again movement had a negative impact on pharmaceutical innovation and the corporations responsible for it.

For the "Make America Healthy Again" movement, Robert F. Kennedy Jr.'s Senate confirmation process was a line in the sand. Even the Democrats' most prominent anti-corporate crusaders like Bernie ...

This analysis was conceived by its author as a trilogy of commentaries in the wake of Decision 16/2 from the 16th Conference ...

We recently published a list of the 12 Most Oversold Healthcare Stocks to Buy Now. In this article, we are going to take a ...

Teva Pharmaceuticals and Alvotech said on Friday they have launched a biosimilar to Johnson & Johnson's autoimmune drug ...

Indian pharmaceutical companies will be able to retain their dominant market share in the U.S. in selling generic drugs even ...

Krupacon 2025 underscores technology, acumen, green initiatives to pave the future of pharma: Nandita Vijayasimha, Bengaluru Friday, February 21, 2025, 08:00 Hrs [IST] The future ...